Coeptis Therapeutics Hldgs I
13F holders, Q2 2024 (June 30)18holders −3
4new positions
7sold out
$0.29avg. 13F price*
At the end of Q2 2024, 18 institutions reported holding Coeptis Therapeutics Hldgs I in their 13F filings, down 3 from Q1 2024. 4 opened new positions and 7 sold out. The largest holders were Creative Planning ($186K), Meteora Capital, LLC ($129K) and Geode Capital Management, LLC ($57K).
- Company
- Coeptis Therapeutics Hldgs I
- CUSIP
- 19207A108
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $11K |
| Exits | 7 | $921K |
All 13F filers, Q1 2024 → Q2 2024: 47,258 shares bought and 3,113,986 shares sold, net −3,066,728 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 18 holders
| Creative Planning | 0.00% | No change | 645,104 | $186K |
| Meteora Capital, LLC | 0.02% | No change | 446,251 | $129K |
| Geode Capital Management, LLC | 0.00% | Add +4.6% | 198,854 | $57K |
| Vanguard Group Inc. | 0.00% | Reduce -7.3% | 100,759 | $29K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 56,149 | $16K |
| Arista Wealth Management, LLC | 0.00% | No change | 47,332 | $14K |
| Sea Otter Advisors LLC | 0.13% | No change | 45,000 | $13K |
| Mint Tower Capital Management B.V. | 0.02% | No change | 45,000 | $13K |
| Virtu Financial LLC | 0.00% | Reduce -29.1% | 23,952 | $7K |
| Jane Street Group, LLC | 0.00% | New | 14,044 | $4K |
| Goldman Sachs Group Inc. | 0.00% | New | 13,161 | $4K |
| Commonwealth Equity Services, LLC | 0.00% | New | 10,000 | $3K |
| HRT Financial LP | 0.00% | Add +9.6% | 13,008 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -0.0% | 9,638 | $3K |
| Osaic Holdings, Inc. | 0.00% | No change | 8,700 | $3K |
| Bank of America Corp. | 0.00% | New | 215 | $62 |
| Semmax Financial Advisors Inc. | 0.00% | No change | 112 | $23 |
| Barclays PLC | 0.00% | No change | 67 | $19 |
"% of holder's portfolio" is COEPTIS THERAPEUTICS HLDGS I's weight in each manager's 13F, not the share of Coeptis Therapeutics Hldgs I the manager owns.